Vimarsana
Biggest News Aggregation in the World

Psoriasis Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Psoriasis Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Psoriasis Center Today - Breaking & Trending Today

Tildrakizumab Enhances Regulatory T Cells, Inhibits PsA Progression in Elderly Patients - Vimarsana News

Tildrakizumab Enhances Regulatory T Cells, Inhibits PsA Progression in Elderly Patients

At the 7-month mark, multivariate analysis revealed patients with psoriasis aged ≥65 years reported a significantly better response to tildrakizumab.

Almirall's Ilumetri® (tildrakizumab) significantly improves wellbeing for patients1 and their relatives2 in moderate-to-severe plaque psoriasis - Vimarsana News

Almirall's Ilumetri® (tildrakizumab) significantly improves wellbeing for patients1 and their relatives2 in moderate-to-severe plaque psoriasis

Almirall's Ilumetri® (tildrakizumab) significantly improves wellbeing for patients1 and their relatives2 in moderate-to-severe plaque psoriasis •      Interim data from the POSITIVE study, presented at the EADV, revealed that tildrakizumab not only significantly improved patien...

Almirall's Ilumetri® (tildrakizumab) Significantly Improves Wellbeing for Patients1 and Their Relatives2 in Moderate-to-Severe Plaque Psoriasis - Vimarsana News

Almirall's Ilumetri® (tildrakizumab) Significantly Improves Wellbeing for Patients1 and Their Relatives2 in Moderate-to-Severe Plaque Psoriasis

BARCELONA, Spain--(BUSINESS WIRE)--Oct 11, 2023--